Building New Businesses (New Areas and Solutions)
First written in FY2018. 5 of 7 entries say "Restated". Latest entry: FY2024.
103 other companies' latest entry also says "Advanced".
- FY2024AdvancedAnnual report
「In 2024, we established a new company, Arilju, with the aim of creating a society in which people can continue working while undergoing cancer treatment.」
As a specific example of building new areas and solutions, a new company was established to provide education, cloud services for companies and health-screening attendance promotion services that support the ability to balance cancer treatment and employment. - FY2023RestatedAnnual report
「Healthcare Business: Taking on challenges in new areas where “only Otsuka can,” resolving unmet medical needs and creating innovation from a unique and diverse research platform」
In parallel with maximizing the value of existing businesses, we continue to build new businesses through new areas in healthcare, external collaboration and our unique research platform. - FY2023-Q2RestatedAnnual report
「The main factors were an increase in gross profit resulting from higher royalty and milestone income from the 4 global products and out-licensed products mentioned above, as well as appropriate control of selling, general and administrative expenses and a reduction in the SG&A ratio through more efficient investment in existing businesses while accelerating investment in new businesses.」
We continue to pursue a policy of accelerating investment in new businesses while making investment in existing businesses more efficient. - FY2022RestatedAnnual report
「Healthcare Business: Taking on challenges in new areas where “only Otsuka can,” resolving unmet medical needs and creating innovation from a unique and diverse research platform」
In parallel with maximizing the value of existing business, we continue to build new areas, technologies and solutions in healthcare. - FY2021RestatedAnnual report
「Healthcare Business: Taking on challenges in new areas where “only Otsuka can,” resolving unmet medical needs and creating innovation from a unique and diverse research platform」
In parallel with maximizing the value of existing businesses, we continue to build new businesses, including new areas in healthcare and new categories and areas in nutraceuticals. - FY2019RestatedAnnual report
「In addition, we will work to strengthen our drug discovery platform and diversify drug discovery modalities through alliances, open innovation, collaboration with venture capital firms and other initiatives, with the aim of achieving sustainable evolution and growth.」
We continue to pursue external collaboration, strengthening the drug discovery platform and diversifying drug discovery modalities to build new areas and solutions. - FY2018First statedAnnual report
「From a long-term perspective, we will work to maximize the value of existing businesses in anticipation of changes in the operating environment and build new businesses (new areas and solutions) in which Otsuka can take on challenges.」
For the first time, a specific policy was set out to build new businesses, including new areas and solutions, in parallel with maximizing the value of existing businesses.